Apr 25, 2024 / 06:00AM GMT
Presentation
Apr 25, 2024 / 06:00AM GMT
=====================
Corporate Participants
=====================
* Hiroyuki Okuzawa
Daiichi Sankyo Company, Limited - President, COO & Representative Director
* Ken Takeshita
Daiichi Sankyo Company, Limited - Head of Research & Development Unit
* Koji Ogawa
Daiichi Sankyo Company, Limited - Managing Executive Officer, Head of Global Corporate Planning & Management and CFO
=====================
Conference Call Participants
=====================
* Hidemaru Yamaguchi
Citigroup Global Markets Japan Inc., Research Division - MD, Analyst & Head of Pan-Asia Healthcare Sector
* Kasumi Haruta
UBS Investment Bank, Research Division - Analyst
* Koichi Mamegano
BofA Securities, Research Division - Analyst
* Miki Sogi
Sanford C. Bernstein & Co., LLC., Research Division - Research Analyst
* Seiji Wakao
JPMorgan Chase & Co, Research Division - VP
* Shinichiro Muraoka
Morgan Stanley, Research
Daiichi Sankyo Co Ltd
(STU:D4S)
€
29.4
-0.21 (-0.71%)
Market Cap: 55.24 Bil
Enterprise Value: 48.46 Bil
PE Ratio: 36.97
PB Ratio: 5.50
GF Score: 93/100 Full Year 2024 Daiichi Sankyo Co Ltd Earnings Presentation Transcript
Apr 25, 2024 / 06:00AM GMT
Release Date Price:
€28.92
(+2.99%)
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot